The global skin antiseptic products market size is expected to reach USD 8.2 billion by 2030, registering a CAGR of 6.9%, from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising incidences of Hospital-Acquired Infections (HAIs) and increasing usage of surgical units and endoscope reprocesses are the key driving factors for the market. Infections caused by bacteria, viruses, and other microorganisms are becoming increasingly common. This has led to an increase in the use of skin antiseptic products for preventing infections and promoting wound healing. The rising number of surgeries being performed is also expected to drive the market during the forecast period.
The demand for alcohol antiseptics for pre-injection and pre-operative skin preparations is increasing significantly. In addition, alcohol antiseptics are being used as a base along with various formulations, such as iodine and chlorhexidine. Exceptional properties of alcohol-based antiseptics for surgical purposes are driving the market. Growing awareness regarding the benefits of skin antiseptic products and increasing R&D funding are creating opportunities for market entrants. Moreover, various programs and informational advertisements conducted by manufacturers and promoters in several countries have boosted awareness about the importance of using antiseptic products for the skin.
Request a free sample copy or view the report summary: Skin Antiseptic Products Market Report
Octenidine is anticipated to be the fastest-growing formulation segment during the forecast period. Octenidine is an internal substitute for chlorhexidine and iodine.
The injection segment led the market in 2022 owing to a rise in the incidence of spinal injuries and the usage of skin antiseptic products for pre-injection skin preparation.
The wipes segment is expected to witness the fastest growth during the forecast period, as wipes are easy to use and possess a lesser risk of contamination.
North America led the global market in 2022 and is anticipated to maintain its position throughout the forecast years, owing to a rise in the number of surgeries being performed and the presence of key companies in the region.
Grand View Research has segmented the global skin antiseptic product market based on formulation, type, application, end-use, and region:
Skin Antiseptic Products Formulation Outlook (Revenue USD Million; 2018 - 2030)
Alcohols
Chlorhexidine
Povidone Iodine
Octenidine
Others
Skin Antiseptic Products Type Outlook (Revenue USD Million; 2018 - 2030)
Solutions
Swab Sticks
Wipes
Skin Antiseptic Products Application Outlook (Revenue USD Million; 2018 - 2030)
Surgeries
Injections
Skin Antiseptic Products End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Research & Manufacturing
Skin Antiseptic Products Regional Outlook (Revenue USD Million; 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Skin Antiseptic Products Market
3M
EcoLab
BD
Sage Products LLC
B.Braun Melsungen AG
Schulke & Mayr GmbH
Cardinal Health
Smith & Nephew
Avrio Health
Microgen
"The quality of research they have done for us has been excellent..."